Literature DB >> 27502070

Erratum to: The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b⁺ Ly6C^hi cells to tumor tissue reduces tumor growth.

Adnan Deronic¹, Sahar Tahvili¹, Tomas Leanderson¹, Fredrik Ivars².

Abstract

Entities: Chemical Disease Gene

Year: 2016 PMID： 27502070 PMCID： PMC4976468 DOI： 10.1186/s12885-016-2649-7

Source DB: PubMed Journal: BMC Cancer ISSN： 1471-2407 Impact factor: 4.430

× No keyword cloud information.

Erratum

After publication of this work [1], it was noted that co-author Sahar Tahvili was inadvertently missed from the author list. This has been corrected here, and in the original article. The publisher would like to apologize for any inconvenience this oversight may have caused.

1 in total

1. The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth.

Authors: Adnan Deronic; Sahar Tahvili; Tomas Leanderson; Fredrik Ivars
Journal: BMC Cancer Date: 2016-07-11 Impact factor: 4.430

1 in total

Erratum to: The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b+ Ly6Chi cells to tumor tissue reduces tumor growth.

Erratum

1. The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth.

Erratum to: The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b⁺ Ly6C^hi cells to tumor tissue reduces tumor growth.